Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression

doi:10.4254/wjh.v6.i9.677

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6604)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

326

WORD

167

HTML

3121

Figures (1-1)

217

Tables (1-3)

199

Sum=4030

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1387

Download

1187

Sum=2574

Sep 27, 2014 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Sep 27, 2014; 6(9): 677-684
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.677

Open in New Tab Full Size Figure Download Figure

Figure 1 Homeostasis model assessement-insulin resistance in the three groups of patients. ^bP < 0.001, HCV vs HBV-HCV and HBV groups. HOMA-IR: Homeostasis model assessement-insulin resistance; HBV: Hepatitis B virus; HCV: Hepatitis C virus.

Citation: Zampino R, Coppola N, Cirillo G, Boemio A, Minichini C, Marrone A, Stanzione M, Starace M, Durante-Mangoni E, Sagnelli E, Restivo L, Salzillo G, Fascione MC, Nevola R, Giudice EMD, Adinolfi LE. Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. World J Hepatol 2014; 6(9): 677-684
URL: https://www.wjgnet.com/1948-5182/full/v6/i9/677.htm
DOI: https://dx.doi.org/10.4254/wjh.v6.i9.677